Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Operating Margin (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Operating Margin for 2 consecutive years, with 2099.8% as the latest value for Q2 2025.

  • Quarterly Operating Margin changed N/A to 2099.8% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 3254.69% through Dec 2025, changed N/A year-over-year, with the annual reading at 2082.8% for FY2025, N/A changed from the prior year.
  • Operating Margin for Q2 2025 was 2099.8% at Mereo BioPharma, down from 6223.33% in the prior quarter.
  • The five-year high for Operating Margin was 6223.33% in Q1 2025, with the low at 2099.8% in Q2 2025.